NCT02528487|Suspended
Study Stopped
Pending financial support
Loading search results
Sponsor study identifier
observational
360
1 country
5
Study Start
May 2015
Actual (reported)Primary Completion
March 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The present study aims to assess the prevalence and impact of comorbid psychiatric disorders among patients with chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation (PR), in order to determine the effects of psychiatric comorbidity on exercise tolerance and physical activity post-PR and HRQoL, as well as to determine the processes by which these psychiatric disorders may impact on these patient behaviours.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2015
Actual (reported)August 17, 2015
Actual (reported)August 19, 2015
Actual (reported)March 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The change in exercise tolerance at 1-year post-PR
Exercise tolerance will be measured with the 6-minute walking test (6MWT).
Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.
The change in health-related quality of life (HRQoL) at 1-year post-PR
Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.
COPD patients will be consecutively recruited at entry in one of six PR programs in the Montreal area: Hôpital du Sacré-Coeur de Montréal (HSCM), Mount Sinai Hospital, Hôtel-Dieu de Montréal (CHUM), and Hôpital Charles-LeMoyne, Jewish Rehabilitation Hospital of Laval, McGill University Health Centre (MUHC).
Jewish Rehabilitation Hospital
Laval, Quebec, Canada
Hopital Charles-Lemoyne
Longueuil, Quebec, Canada
Hopital du Sacre-Coeur de Montreal
Montreal, Quebec, H4J1C5, Canada
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada
Mount-Sinai Hospital
Montreal, Quebec, Canada
Grégory Moullec, Ph.D.
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
First Submitted
August 17, 2015
First Posted
August 19, 2015
Study Start
May 2015
Actual (reported)Primary Completion
March 2023
Estimated (date passed)Feasibility of Dance in People With COPD
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 15, 2019
Record last verified: 2019-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: